ArticleTherapeutic innovation & regulatory science2026
Hierarchical Transit Compartment Model to Describe Absorption Delay in Orally Administered Drugs in Heterogeneous Populations.
Article in Therapeutic innovation & regulatory science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following oral administration of a drug, we observe an absorption delay before the drug enters systemic circulation. This delay is attributed to the time taken for disintegration of the drug delivery system, drug dissolution from the delivery system, migration of the drug to the absorption site, and transfer of the drug through absorption site tissue. Additionally, pharmacokinetic profiles of such drugs frequently exhibit substantial variability among individuals from different sub-populations. In this article, we present a hierarchical transit compartment model that systematically describes absorption delay in orally administered drugs, and explicitly accounts for between sub-population variations. Such a transit compartment model can be regarded as an accurate representation of the underlying physiology, that also accounts for the influence of drug formulation and the physicochemical properties of the drug on the absorption process. Here, we specify non-informative priors on the pharmacokinetic parameters of interest, and develop an efficient computational scheme based on Hamiltonian Monte Carlo algorithm to conduct inference. The proposed joint inferential procedure ensures valid uncertainty quantification, and enables us to conduct simultaneous inference on sub-population specific as well as population parameters. The utility of the methodology is demonstrated through simulation studies, and two case studies.
Indexed as
Identifiers
41634235What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.